Company intelligence / Profile preview

Dow Pharmaceutical Sciences

Petaluma, California, United States
Ownership
Private
Development stage
Other
01

Overview

Dow Pharmaceutical Sciences was a leading dermatology-focused contract research and product development company specializing in topical drug formulations for pharmaceutical and biotech clients. At the time of its acquisition by Valeant Pharmaceuticals in December 2008 for $285 million, it had one newly approved topical medication and five additional dermatology programs—three of which were in Phase II trials. The company provided end-to-end services including formulation optimization using advanced permeation models, regulatory consulting, analytical support, cGMP clinical manufacturing and labeling. Its expertise spanned both small molecules and combination drugs for skin diseases such as acne vulgaris and rosacea.

Therapeutic areas
DermatologyInfectious Diseases
Modalities
Small moleculeCombination drug (e.g., benzoyl peroxide + clindamycin phosphate)Topical formulation (as a delivery modality)
Industry
Contract Research Organization
02

Partnerships

Provided outsourced R&D/product development services to multiple pharmaceutical and biotechnology companies as external sponsors.

Beyond the preview

Go deeper on Dow Pharmaceutical Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dow Pharmaceutical Sciences.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call